Source: Annual Congress 2012 - New biomarkers for lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
R. Aguilar, E. Vázquez, A. Ruiz, R. Castilla, R. González, J. Grávalos, T. García, J. L. Gómez-Ariza, J. A. Maldonado, A. Pereira-Vega (Huelva, Spain). Lung cancer metabolomics in plasma, urine and broncheoalveolar lavage. A pilot study. Eur Respir J 2012; 40: Suppl. 56, 4217

Member's Comments

No comment yet.

Related content which might interest you: Comparative metabolomic study of lung cancer based on serum, urine and bronchoalveolar lavage fluid. Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study Source: ERJ Open Res, 7 (1) 00489-2020; 10.1183/23120541.00489-2020 Year: 2021 Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Serum and bronchial aspiration fluid HE-4 levels in lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Utility of bronchoalveolar lavage in the determination of lung asbestos burden in Barcelona, Spain Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 The value of bacterial culture in patients with suspected lung cancer evaluated by bronchoscopy: A prospective study of 155 patients Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study Source: International Congress 2016 – ILD pathogenesis Year: 2016 Liquid biopsy in patients with adenocarcinoma -comparison between bronchoalveolar lavage (BAL) and blood samples Source: Virtual Congress 2020 – Novelties in interventional pulmonology: expanding horizons Year: 2020 Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Cytokine profile in lung cancer microenvironment- analysis of bronchoalveolar lavage fluid by Luminex assay Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Insights from RNA-sequencing of bronchoalveolar lavage cells in a large sarcoidosis cohort Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017 Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF) Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006